Approval · Notice of Compliance 29712 · 2022
PMS-EZETIMIBE: Notice of Compliance 29712
Issued December 15, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29712
- Date
- December 15, 2022
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of Indication. Update to the Product Monograph, Package Insert, and Labels
- Canadian reference product
- EZETROL
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-EZETIMIBE | Not yet assigned | — |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB